{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:14:20Z","timestamp":1775063660651,"version":"3.50.1"},"reference-count":20,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"\n Background & objectives:<\/jats:title>\n Cells and cell proportions may indicate the equilibrium status of the immune system. The present study was conducted to evaluate the role of cytokines and the immunocompetent cells as biomarkers of remission in rheumatoid arthritis (RA) patients intended to withdraw or reduce disease-modifying anti-rheumatic drug (DMARD) treatment.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n This prospective observational study involved newly diagnosed and treated RA patients who fulfilled 2010 American College of Rheumatology (ACR)\/European League Against Rheumatism (EULAR) criteria. The patients were classified based on disease activity score (DAS)28-C-reactive protein (CRP)(3) score into remission (\u22642.6) and treatment-na\u00efve\/active (>2.6) groups. Remission patients were followed up for six months and were reclassified into those in sustained remission (\u22642.6) and relapse (>2.6) based on the DAS28-CRP(3) score. Various cytokines and cell surface markers were quantitated using whole blood samples, and the CD3+<\/jats:sup>\/CD19+<\/jats:sup> and FOXP3+<\/jats:sup>\/CD4+<\/jats:sup> ratios were calculated. The clinical, demographic, cytokine and cellular phenotype characteristics were compared between remission and treatment-na\u00efve groups. The factors associated with sustained remission were verified.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Of the 72 patients, 52 were in remission and 20 were DMARD na\u00efve and had active disease. Duration of illness, interleukin-6 (IL-6) and IL-10 were significantly different between remission and treatment na\u00efve\/active disease patients. Increased likelihood for achieving sustained remission was noted in RA patients with baseline NLR \u22642. Other demographic\/clinical variables and cell phenotypes, namely age, gender, duration of illness, CD3+<\/jats:sup>, CD4+<\/jats:sup>, FOXP3+<\/jats:sup>, CD19+<\/jats:sup>, CD3+<\/jats:sup>\/CD19+<\/jats:sup>, FOXP3+<\/jats:sup>\/CD4+<\/jats:sup> and cytokines - IL-6 and IL-10 were not associated with sustained remission.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n The present preliminary study highlighted the potential of NLR in predicting sustained remission in RA patients with a cut-off <2. Further study with a large sample size should be done to confirm this finding.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1676_18","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T09:25:10Z","timestamp":1602926710000},"page":"234-243","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Potential of neutrophil to lymphocyte ratio in predicting sustained remission in rheumatoid arthritis compared to other immune activation markers"],"prefix":"10.25259","volume":"152","author":[{"given":"S.","family":"Chandrashekara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak Chikkulikere","family":"Lingaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Renuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.R.","family":"Anupama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-7-20241212","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.2010.136556","article-title":"Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: Exploratory analyses from the BeSt study","volume":"70","author":"Klarenbeek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R2-7-20241212","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R3-7-20241212","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/ar2752","article-title":"Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs","volume":"11","author":"Mauri","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R4-7-20241212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1759720X17720366","article-title":"Sustained remission in rheumatoid arthritis: Latest evidence and clinical considerations","volume":"9","author":"Ajeganova","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R5-7-20241212","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R8-7-20241212","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4081\/reumatismo.2015.838","article-title":"Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis","volume":"67","author":"Chandrashekara","year":"2015","journal-title":"Reumatismo"},{"key":"R9-7-20241212","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/1756-185X.13157","article-title":"Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis","volume":"20","author":"Chandrashekara","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R10-7-20241212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejr.2013.03.005","article-title":"Deficient or abundant but unable to fight Estimation of circulating Foxp3+ T regulatory cells and their counteracting FoxP3 In rheumatoid arthritis and correlation with disease activity","volume":"35","author":"Abaza","year":"2013","journal-title":"Egypt Rheumatol"},{"key":"R11-7-20241212","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","article-title":"Disturbed Th17\/Treg balance in patients with rheumatoid arthritis","volume":"32","author":"Niu","year":"2012","journal-title":"Rheumatol Int"},{"key":"R12-7-20241212","first-page":"87","article-title":"CD4+ CD25+ CD127low regulatory T Cells as indicator of rheumatoid arthritis disease activity","volume":"23","author":"Khattab","year":"2016","journal-title":"Egypt J Immunol"},{"key":"R13-7-20241212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/art.39408","article-title":"Phenotypic, functional, and gene expression profiling of peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) treg cells in patients with chronic rheumatoid arthritis","volume":"68","author":"Walter","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R14-7-20241212","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar4545","article-title":"CD4+ CD25+\/highCD127low\/\u2013 regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints-analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood","volume":"16","author":"Moradi","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R15-7-20241212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13075-015-0526-4","article-title":"Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: Increase in regulatory T cells correlates with clinical response","volume":"17","author":"Kikuchi","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R16-7-20241212","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/14397595.2013.854079","article-title":"Drug free REmission\/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study","volume":"24","author":"Nishimoto","year":"2014","journal-title":"Mod Rheumatol"},{"key":"R17-7-20241212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cyto.2014.10.031","article-title":"Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy","volume":"74","author":"Saxena","year":"2015","journal-title":"Cytokine"},{"key":"R18-7-20241212","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jcla.21908","article-title":"The association between neutrophil\/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis","volume":"30","author":"Mercan","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"R19-7-20241212","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/apm.12722","article-title":"Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases","volume":"25","author":"Yang","year":"2017","journal-title":"APMIS"},{"key":"R20-7-20241212","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00393-016-0187-y","article-title":"New inflammatory markers in early rheumatoid arthritis","volume":"77","author":"Zengin","year":"2018","journal-title":"Z Rheumatol"},{"key":"R21-7-20241212","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/14397595.2016.1214340","article-title":"Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy","volume":"27","author":"Ghang","year":"2017","journal-title":"Mod Rheumatol"},{"key":"R22-7-20241212","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/s41598-017-11398-4","article-title":"The relationship between hematological indices and autoimmune rheumatic diseases (ARDs), a meta-analysis","volume":"7","author":"Hao","year":"2017","journal-title":"Sci Rep"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_1676_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:03:24Z","timestamp":1751497404000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/potential-of-neutrophil-to-lymphocyte-ratio-in-predicting-sustained-remission-in-rheumatoid-arthritis-compared-to-other-immune-activation-markers\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1676_18","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}